Generics Maker Settles Imitrex Suit With Glaxo
Cobalt Laboratories Inc., an affiliate of Cobalt Pharmaceuticals, followed in the footsteps of Spectrum Pharmaceuticals Inc. and Dr. Reddy’s Laboratories by settling with Glaxo over sumatriptan succinate tablets, Cobalt said on Wednesday.
As part of the settlement, Cobalt may distribute generic Imitrex in the U.S. in the first quarter of 2009, the generics maker said.
The remaining terms of...
To view the full article, register now.